The CheckMate 9LA Trial for Stage IV/Recurrent Non-Small Cell Lung Cancer
0 Views
administrator
07/07/23
Martin Reck, MD, PhD, presents data from the CheckMate 9LA trial of nivolumab, ipilimumab, and 2 cycles of platinum-doublet chemotherapy for stage IV/recurrent non-small cell lung cancer.
Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive
-
Category
Show more
Facebook Comments
No comments found